{"id":6625,"date":"2026-05-25T15:33:00","date_gmt":"2026-05-25T10:03:00","guid":{"rendered":"https:\/\/operonstrategist.com\/?p=6625"},"modified":"2026-05-25T15:33:00","modified_gmt":"2026-05-25T10:03:00","slug":"nb-opinions-for-ce-marking-and-us-fda-ddcp","status":"publish","type":"post","link":"https:\/\/operonstrategist.com\/dz-en\/nb-opinions-for-ce-marking-and-us-fda-ddcp\/","title":{"rendered":"Navigating NB Opinions for CE Marking and US FDA Regulatory Guidance for DDCP"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"6625\" class=\"elementor elementor-6625\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-3b346a70 e-flex e-con-boxed e-con e-parent\" data-id=\"3b346a70\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-5e612034 elementor-widget elementor-widget-heading\" data-id=\"5e612034\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Navigating NB Opinions for CE Marking and US FDA Regulatory Guidance for DDCP<\/h2>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-5304cc22 e-flex e-con-boxed e-con e-parent\" data-id=\"5304cc22\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-1a8e2f e-con-full e-flex e-con e-child\" data-id=\"1a8e2f\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-47eedaeb elementor-widget elementor-widget-heading\" data-id=\"47eedaeb\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Overview - NB Opinions for CE Marking and US FDA Regulatory\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6902238f elementor-widget elementor-widget-text-editor\" data-id=\"6902238f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><span style=\"font-weight: 400;\">Obtaining market approval for new devices is a critical step that requires compliance with rigorous standards. Two key regulatory pathways\u2014those governed by European Notified Bodies and the US Food and Drug Administration (FDA)\u2014play pivotal roles in the market entry of medical devices. When it comes to Drug-Device Combination Products (DDCP), understanding how to navigate both systems can make the difference between a successful product launch and costly delays. In this blog, we will explore the roles of Notified Body (NB) opinions in the European Union (EU) and the US FDA regulatory guidance concerning DDCP.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-32c37b9d e-con-full e-flex e-con e-child\" data-id=\"32c37b9d\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t<div class=\"elementor-element elementor-element-64fd619a e-con-full e-flex e-con e-child\" data-id=\"64fd619a\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-7da65b23 elementor-widget elementor-widget-heading\" data-id=\"7da65b23\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h4 class=\"elementor-heading-title elementor-size-default\">Regulatory Excellence for Global Medical Device Markets<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-68dbd893 elementor-widget elementor-widget-wpforms\" data-id=\"68dbd893\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"wpforms.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"wpforms-container wpforms-container-full wpforms-render-modern\" id=\"wpforms-6203\"><form id=\"wpforms-form-6203\" class=\"wpforms-validate wpforms-form wpforms-ajax-form\" data-formid=\"6203\" method=\"post\" enctype=\"multipart\/form-data\" action=\"\/dz-en\/wp-json\/wp\/v2\/posts\/6625\" data-token=\"ec74508000ccae4945515a950d3da251\" data-token-time=\"1780156889\"><noscript class=\"wpforms-error-noscript\">Please enable JavaScript in your browser to complete this form.<\/noscript><div id=\"wpforms-error-noscript\" style=\"display: none;\">Please enable JavaScript in your browser to complete this form.<\/div><div class=\"wpforms-field-container\"><div id=\"wpforms-6203-field_1-container\" class=\"wpforms-field wpforms-field-name\" data-field-id=\"1\"><label class=\"wpforms-field-label wpforms-label-hide\" for=\"wpforms-6203-field_1\" aria-hidden=\"false\">Name <span class=\"wpforms-required-label\" aria-hidden=\"true\">*<\/span><\/label><input type=\"text\" id=\"wpforms-6203-field_1\" class=\"wpforms-field-large wpforms-field-required\" name=\"wpforms[fields][1]\" placeholder=\"Name*\" aria-errormessage=\"wpforms-6203-field_1-error\" required><\/div>\t\t<div id=\"wpforms-6203-field_5-container\"\n\t\t\tclass=\"wpforms-field wpforms-field-text\"\n\t\t\tdata-field-type=\"text\"\n\t\t\tdata-field-id=\"5\"\n\t\t\t>\n\t\t\t<label class=\"wpforms-field-label\" for=\"wpforms-6203-field_5\" >Paragraph Phone Name<\/label>\n\t\t\t<input type=\"text\" id=\"wpforms-6203-field_5\" class=\"wpforms-field-medium\" name=\"wpforms[fields][5]\" >\n\t\t<\/div>\n\t\t<div id=\"wpforms-6203-field_2-container\" class=\"wpforms-field wpforms-field-email\" data-field-id=\"2\"><label class=\"wpforms-field-label wpforms-label-hide\" for=\"wpforms-6203-field_2\" aria-hidden=\"false\">Email <span class=\"wpforms-required-label\" aria-hidden=\"true\">*<\/span><\/label><input type=\"email\" id=\"wpforms-6203-field_2\" class=\"wpforms-field-large wpforms-field-required\" name=\"wpforms[fields][2]\" placeholder=\"Email*\" spellcheck=\"false\" aria-errormessage=\"wpforms-6203-field_2-error\" required><\/div><div id=\"wpforms-6203-field_3-container\" class=\"wpforms-field wpforms-field-phone\" data-field-id=\"3\"><label class=\"wpforms-field-label wpforms-label-hide\" for=\"wpforms-6203-field_3\" aria-hidden=\"false\">Phone <span class=\"wpforms-required-label\" aria-hidden=\"true\">*<\/span><\/label><input type=\"tel\" id=\"wpforms-6203-field_3\" class=\"wpforms-field-large wpforms-field-required wpforms-smart-phone-field\" data-rule-smart-phone-field=\"true\" name=\"wpforms[fields][3]\" placeholder=\"Phone*\" aria-label=\"Phone\" aria-errormessage=\"wpforms-6203-field_3-error\" required><\/div><div id=\"wpforms-6203-field_4-container\" class=\"wpforms-field wpforms-field-textarea\" data-field-id=\"4\"><label class=\"wpforms-field-label wpforms-label-hide\" for=\"wpforms-6203-field_4\" aria-hidden=\"false\">Paragraph Text <span class=\"wpforms-required-label\" aria-hidden=\"true\">*<\/span><\/label><textarea id=\"wpforms-6203-field_4\" class=\"wpforms-field-medium wpforms-field-required\" name=\"wpforms[fields][4]\" placeholder=\"Message\" aria-errormessage=\"wpforms-6203-field_4-error\" required><\/textarea><\/div><script>\n\t\t\t\t( function() {\n\t\t\t\t\tconst style = document.createElement( 'style' );\n\t\t\t\t\tstyle.appendChild( document.createTextNode( '#wpforms-6203-field_5-container { position: absolute !important; overflow: hidden !important; display: inline !important; height: 1px !important; width: 1px !important; z-index: -1000 !important; padding: 0 !important; } #wpforms-6203-field_5-container input { visibility: hidden; } #wpforms-conversational-form-page #wpforms-6203-field_5-container label { counter-increment: none; }' ) );\n\t\t\t\t\tdocument.head.appendChild( style );\n\t\t\t\t\tdocument.currentScript?.remove();\n\t\t\t\t} )();\n\t\t\t<\/script><\/div><!-- .wpforms-field-container --><div class=\"wpforms-submit-container\" ><input type=\"hidden\" name=\"wpforms[id]\" value=\"6203\"><input type=\"hidden\" name=\"page_title\" value=\"\"><input type=\"hidden\" name=\"page_url\" value=\"https:\/\/operonstrategist.com\/dz-en\/wp-json\/wp\/v2\/posts\/6625\"><input type=\"hidden\" name=\"url_referer\" value=\"\"><button type=\"submit\" name=\"wpforms[submit]\" id=\"wpforms-submit-6203\" class=\"wpforms-submit\" data-alt-text=\"Sending...\" data-submit-text=\"Submit\" aria-live=\"assertive\" value=\"wpforms-submit\">Submit<\/button><img decoding=\"async\" src=\"https:\/\/operonstrategist.com\/wp-content\/plugins\/wpforms\/assets\/images\/submit-spin.svg\" class=\"wpforms-submit-spinner\" style=\"display: none;\" width=\"26\" height=\"26\" alt=\"Loading\"><\/div><\/form><\/div>  <!-- .wpforms-container -->\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-796b7949 e-flex e-con-boxed e-con e-parent\" data-id=\"796b7949\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-3762fda9 elementor-widget elementor-widget-heading\" data-id=\"3762fda9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">What is a Drug-Device Combination Product (DDCP)?<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-75965dd7 elementor-widget elementor-widget-text-editor\" data-id=\"75965dd7\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><span style=\"font-weight: 400;\">Drug-Device Combination Products (DDCP) integrate both a medicinal product and a medical device into a single entity. These products are unique in that they involve both pharmacological and mechanical modes of action, making their regulation more complex. Examples include prefilled syringes, inhalers with integrated drug components, and drug-eluting stents.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-80eddbd elementor-widget elementor-widget-heading\" data-id=\"80eddbd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Regulatory Challenges for DDCP<\/h2>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-44497968 e-con-full e-flex e-con e-child\" data-id=\"44497968\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-1ebff65 elementor-widget elementor-widget-text-editor\" data-id=\"1ebff65\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><span style=\"font-weight: 400;\">Due to their hybrid nature, DDCPs are subject to a range of regulatory requirements that span both medical device and pharmaceutical regulations. As such, manufacturers must consider multiple layers of regulatory scrutiny, depending on the intended market. Understanding the approval processes in the EU and US is crucial for navigating this regulatory landscape.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b7e9d52 elementor-widget elementor-widget-heading\" data-id=\"b7e9d52\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Notified Body Opinions in the EU<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6469276 elementor-widget elementor-widget-text-editor\" data-id=\"6469276\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><span style=\"font-weight: 400;\">In the European Union, Drug-Device Combination Products fall under the scope of both the Medical Device Regulation (MDR) 2017\/745 and pharmaceutical regulations. The European Medicines Agency (EMA) evaluates the medicinal component, while a Notified Body (NB) is responsible for assessing the device aspect.<\/span><\/p><p><span style=\"font-weight: 400;\">Know more about the <\/span><a href=\"https:\/\/operonstrategist.com\/services\/regulatory-approvals\/ce-marking\/\"><span style=\"font-weight: 400;\">regulatory services of CE marking for medical devices.<\/span><\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-10d4071 elementor-widget elementor-widget-heading\" data-id=\"10d4071\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">How Notified Bodies Work in DDCP Evaluations?\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-472dbde elementor-widget elementor-widget-text-editor\" data-id=\"472dbde\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><span style=\"font-weight: 400;\">For DDCPs that fall under Article 117 of the MDR, an NB opinion is required when the device component critically impacts the safety and performance of the combination product. The NB will evaluate the device\u2019s conformity with the essential requirements of MDR, such as safety, effectiveness, and quality standards.\u00a0<\/span><\/p><p><span style=\"font-weight: 400;\">If the device component passes the review, the Notified Body issues an opinion that becomes a part of the overall marketing authorization application submitted to the EMA. Without this NB opinion, the EMA will not approve the combination product.\u00a0<\/span><\/p><p><span style=\"font-weight: 400;\">Key Points to Consider in NB Opinions for DDCP:<\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/p><ul><li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Timing: Obtaining an NB opinion can add time to the regulatory approval process, so it\u2019s crucial to engage with a Notified Body early.\u00a0<\/span><\/li><\/ul><ul><li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Documentation: Clear technical documentation about the device\u2019s design, testing, and performance is essential for NB approval.\u00a0<\/span><\/li><\/ul><ul><li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Device-Drug Interactions: The NB will evaluate interactions between the medicinal and device components to ensure safety and effectiveness.\u00a0<\/span><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-81272a5 elementor-widget elementor-widget-heading\" data-id=\"81272a5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">US FDA Regulatory Guidance for DDCP\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-63a1439 elementor-widget elementor-widget-text-editor\" data-id=\"63a1439\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><span style=\"font-weight: 400;\">In the United States, the regulation of Drug-Device Combination Products falls under the jurisdiction of the FDA. Depending on the product\u2019s primary mode of action (PMOA), it is regulated by the Center for Drug Evaluation and Research (CDER), the Center for Devices and Radiological Health (CDRH), or the Center for Biologics Evaluation and Research (CBER).\u00a0<\/span><\/p><p><span style=\"font-weight: 400;\">Know more about <\/span><a href=\"https:\/\/operonstrategist.com\/services\/regulatory-approvals\/fda-510k\/\"><span style=\"font-weight: 400;\">US FDA regulations for medical devices.<\/span><\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0c1a162 elementor-widget elementor-widget-heading\" data-id=\"0c1a162\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Premarket Approval Pathways for DDCP\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7b360d6 elementor-widget elementor-widget-text-editor\" data-id=\"7b360d6\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><span style=\"font-weight: 400;\">DDCPs are reviewed based on their primary function, which determines the lead FDA center. If the drug component is the primary action, CDER will lead the review, while CDRH takes the lead if the device is the primary component.\u00a0<\/span><\/p><p><span style=\"font-weight: 400;\">The FDA provides a specific regulatory framework under the<\/span><a href=\"https:\/\/operonstrategist.com\/services\/regulatory-approvals\/design-and-development-documentation\/drug-device-combination-products\/\"><span style=\"font-weight: 400;\"> Combination Product Regulations (21 CFR Part 3)<\/span><\/a><span style=\"font-weight: 400;\">, outlining how these products are assessed. Unlike the EU system, where Notified Bodies play a role, the FDA\u2019s Office of Combination Products (OCP) coordinates between the relevant centers and provides guidance to the manufacturer on the regulatory pathway.\u00a0<\/span><\/p><h3><span style=\"font-weight: 400;\">Key Points in FDA Guidance for DDCP:<\/span><\/h3><ol><li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Primary Mode of Action (PMOA): Determining whether the drug or device aspect of the product is primary is the first step in selecting the right approval pathway.\u00a0<\/span><\/li><li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">User Safety: The FDA will assess the combination product\u2019s safety and performance, including how the drug and device components interact.\u00a0<\/span><\/li><li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Human Factors Testing: The usability of the device component must be tested to ensure patient safety and effectiveness.\u00a0<\/span><\/li><li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Submission Type: Manufacturers may need to file a Premarket Approval (PMA), New Drug Application (NDA), or 510(k), depending on the combination product\u2019s PMOA and risk classification.\u00a0<\/span><\/li><\/ol><h3><span style=\"font-weight: 400;\">FDA vs. NB: Key Differences in Regulatory Approach<\/span><\/h3><p><span style=\"font-weight: 400;\">While the FDA and EU systems share some common principles, there are notable differences between them. For instance, in the EU, a separate NB opinion is often required, whereas the FDA has a more centralized system where the OCP helps streamline the process.\u00a0<\/span><\/p><p><span style=\"font-weight: 400;\">In the EU, obtaining an NB opinion can add complexity and time to the process, but it provides a valuable checkpoint to ensure the device component complies with MDR requirements. In contrast, the FDA\u2019s PMOA determination helps simplify the regulatory pathway for combination products by clearly establishing which center will take the lead in the review.\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e81550f elementor-widget elementor-widget-heading\" data-id=\"e81550f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Streamlining Regulatory Approval for Drug-Device Combination Products\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2e8c308 elementor-widget elementor-widget-text-editor\" data-id=\"2e8c308\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><span style=\"font-weight: 400;\">Navigating the regulatory landscape for Drug-Device Combination Products is complex, but understanding the differences between the EU\u2019s Notified Body opinion process and the US FDA\u2019s guidance is crucial. Early planning, clear documentation, and an understanding of the primary mode of action (PMOA) are vital for ensuring a smooth regulatory process.\u00a0<\/span><\/p><p><span style=\"font-weight: 400;\">Whether you\u2019re targeting the European or US markets, collaborating with regulatory experts like Operon Strategist can help streamline your approval process, ensuring compliance with both NB and FDA requirements. Operon Strategist provides end-to-end support for medical device manufacturers, offering <\/span><a href=\"https:\/\/operonstrategist.com\/elevateplus\/\"><span style=\"font-weight: 400;\">regulatory consulting<\/span><\/a><span style=\"font-weight: 400;\"> and <\/span><a href=\"https:\/\/operonstrategist.com\/services\/turnkey-project\/\"><span style=\"font-weight: 400;\">turnkey project management services<\/span><\/a><span style=\"font-weight: 400;\"> tailored to your needs.\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Overview &#8211; NB Opinions for CE Marking and US FDA Regulatory Obtaining market approval for new devices is a critical step that requires compliance with rigorous standards. Two key regulatory pathways\u2014those governed by European Notified Bodies and the US Food and Drug Administration (FDA)\u2014play pivotal roles in the market entry of medical devices. When it [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":6631,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[55],"tags":[],"class_list":["post-6625","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-regulatory"],"_links":{"self":[{"href":"https:\/\/operonstrategist.com\/dz-en\/wp-json\/wp\/v2\/posts\/6625","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/operonstrategist.com\/dz-en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/operonstrategist.com\/dz-en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/operonstrategist.com\/dz-en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/operonstrategist.com\/dz-en\/wp-json\/wp\/v2\/comments?post=6625"}],"version-history":[{"count":0,"href":"https:\/\/operonstrategist.com\/dz-en\/wp-json\/wp\/v2\/posts\/6625\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/operonstrategist.com\/dz-en\/wp-json\/wp\/v2\/media\/6631"}],"wp:attachment":[{"href":"https:\/\/operonstrategist.com\/dz-en\/wp-json\/wp\/v2\/media?parent=6625"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/operonstrategist.com\/dz-en\/wp-json\/wp\/v2\/categories?post=6625"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/operonstrategist.com\/dz-en\/wp-json\/wp\/v2\/tags?post=6625"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}